176 related articles for article (PubMed ID: 16281067)
21. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
Kartal M; Saydam G; Sahin F; Baran Y
Nutr Cancer; 2011; 63(4):637-44. PubMed ID: 21500096
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.
Schmelz K; Wieder T; Tamm I; Müller A; Essmann F; Geilen CC; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2004 Sep; 23(40):6743-59. PubMed ID: 15273737
[TBL] [Abstract][Full Text] [Related]
23. Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Hayashi K; Takenaka K; Nishimura Y; Sakai N; Nozawa Y
Cell Death Differ; 2000 Sep; 7(9):761-72. PubMed ID: 11042671
[TBL] [Abstract][Full Text] [Related]
24. Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT(388)-granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSF.
Senchenkov A; Han TY; Wang H; Frankel AE; Kottke TJ; Kaufmann SH; Cabot MC
Blood; 2001 Sep; 98(6):1927-34. PubMed ID: 11535531
[TBL] [Abstract][Full Text] [Related]
25. Bortezomib and sphingosine kinase inhibitor interact synergistically to induces apoptosis in BCR/ABl+ cells sensitive and resistant to STI571 through down-regulation Mcl-1.
Li QF; Yan J; Zhang K; Yang YF; Xiao FJ; Wu CT; Wang H; Wang LS
Biochem Biophys Res Commun; 2011 Feb; 405(1):31-6. PubMed ID: 21195056
[TBL] [Abstract][Full Text] [Related]
26. P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells.
Bielak-Mijewska A; Piwocka K; Magalska A; Sikora E
Cancer Chemother Pharmacol; 2004 Feb; 53(2):179-85. PubMed ID: 14530869
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine kinase-1--a potential therapeutic target in cancer.
Cuvillier O
Anticancer Drugs; 2007 Feb; 18(2):105-10. PubMed ID: 17159597
[TBL] [Abstract][Full Text] [Related]
28. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.
Uchida Y; Itoh M; Taguchi Y; Yamaoka S; Umehara H; Ichikawa S; Hirabayashi Y; Holleran WM; Okazaki T
Cancer Res; 2004 Sep; 64(17):6271-9. PubMed ID: 15342415
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells.
Perkins C; Kim CN; Fang G; Bhalla KN
Cancer Res; 1998 Oct; 58(20):4561-6. PubMed ID: 9788601
[TBL] [Abstract][Full Text] [Related]
30. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.
Leroux ME; Auzenne E; Evans R; Hail N; Spohn W; Ghosh SC; Farquhar D; McDonnell T; Klostergaard J
Prostate; 2007 Nov; 67(15):1699-717. PubMed ID: 17879964
[TBL] [Abstract][Full Text] [Related]
31. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression.
Bektas M; Jolly PS; Müller C; Eberle J; Spiegel S; Geilen CC
Oncogene; 2005 Jan; 24(1):178-87. PubMed ID: 15637591
[TBL] [Abstract][Full Text] [Related]
32. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine.
Malik F; Kumar A; Bhushan S; Khan S; Bhatia A; Suri KA; Qazi GN; Singh J
Apoptosis; 2007 Nov; 12(11):2115-33. PubMed ID: 17874299
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a human myeloid leukemia cell line highly resistant to taxol.
Bhalla K; Huang Y; Tang C; Self S; Ray S; Mahoney ME; Ponnathpur V; Tourkina E; Ibrado AM; Bullock G
Leukemia; 1994 Mar; 8(3):465-75. PubMed ID: 7907395
[TBL] [Abstract][Full Text] [Related]
34. Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60).
Kachalaki S; Baradaran B; Majidi J; Yousefi M; Shanehbandi D; Mohammadinejad S; Mansoori B
Biomed Pharmacother; 2015 Oct; 75():100-4. PubMed ID: 26463638
[TBL] [Abstract][Full Text] [Related]
35. Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640.
White MD; Chan L; Antoon JW; Beckman BS
Anticancer Res; 2013 Sep; 33(9):3573-9. PubMed ID: 24023282
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells.
Nava VE; Cuvillier O; Edsall LC; Kimura K; Milstien S; Gelmann EP; Spiegel S
Cancer Res; 2000 Aug; 60(16):4468-74. PubMed ID: 10969794
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo induction of apoptosis by sphingosine and N, N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells.
Shirahama T; Sweeney EA; Sakakura C; Singhal AK; Nishiyama K; Akiyama S; Hakomori S; Igarashi Y
Clin Cancer Res; 1997 Feb; 3(2):257-64. PubMed ID: 9815681
[TBL] [Abstract][Full Text] [Related]
38. Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.
Morad SA; Tan SF; Feith DJ; Kester M; Claxton DF; Loughran TP; Barth BM; Fox TE; Cabot MC
Biochim Biophys Acta; 2015 Jul; 1851(7):919-28. PubMed ID: 25769964
[TBL] [Abstract][Full Text] [Related]
39. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
[TBL] [Abstract][Full Text] [Related]
40. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
